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Background: Cuffless blood pressure (BP) monitoring devices, based on pulse transit time, are being developed as an easy-to-use,
more convenient, fast, and relatively cheap alternative to conventional BP measuring devices based on cuff occlusion. Thereby
they may provide a great alternative to BP self-measurement.
Objective: The objective of our study was to evaluate the performance of the first release of the Checkme Health Monitor
(Viatom Technology), a cuffless BP monitor, in a real-life setting. Furthermore, we wanted to investigate whether the posture of
the volunteer and the position of the device relative to the heart level would influence its outcomes.
Methods: Study volunteers fell into 3 BP ranges: high (>160 mmHg), normal (130–160 mmHg), and low (<130 mmHg). All
requirements for test environment, observer qualification, volunteer recruitment, and BP measurements were met according to
the European Society of Hypertension International Protocol (ESH-IP) for the validation of BP measurement devices. After
calibrating the Checkme device, we measured systolic BP with Checkme and a validated, oscillometric reference BP monitor
(RM). Measurements were performed in randomized order both in supine and in sitting position, and with Checkme at and above
heart level.
Results: We recruited 52 volunteers, of whom we excluded 15 (12 due to calibration failure with Checkme, 3 due to a variety
of reasons). The remaining 37 volunteers were divided into low (n=14), medium (n=13), and high (n=10) BP ranges. There were
18 men and 19 women, with a mean age of 54.1 (SD 14.5) years, and mean recruitment systolic BP of 141.7 (SD 24.7) mmHg.
BP results obtained by RM and Checkme correlated well. In the supine position, the difference between the RM and Checkme
was >5 mmHg in 17 of 37 volunteers (46%), of whom 9 of 37 (24%) had a difference >10 mmHg and 5 of 37 (14%) had a
difference >15 mmHg.
Conclusions: BP obtained with Checkme correlated well with RM BP, particularly in the position (supine) in which the device
was calibrated. These preliminary results are promising for conducting further research on cuffless BP measurement in the clinical
and outpatient settings.
(J Med Internet Res 2016;18(5):e85)   doi:10.2196/jmir.5414
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Noninvasive blood pressure (BP) monitors based on cuff
occlusion are used widely in and outside of care facilities. These
devices measure systolic (SBP) and diastolic blood pressure
(DBP) by auscultation [1] or oscillometry [2]. Disadvantages
of these measurements are discomfort for the patient because
of painful cuff inflation, which may influence BP outcome, and
the impossibility of continuous or semicontinuous BP
monitoring due to the necessity of cuff inflation and deflation.
Measurements can also vary between users, for example, patients
or health care workers, due to interindividual differences in use.
Although self-measurement of BP using noninvasive BP
monitors has been shown to produce significantly greater BP
reduction in patients with hypertension than standard care using
clinic-based BP measurements [3], it is not common practice
because it is time consuming and has high overall costs because
of expensive equipment and technologies [4].
To overcome the disadvantages of BP measurements based on
cuff occlusion and to provide easy-to-use devices for reliable
self-measurement, pocket-sized BP monitoring devices without
the need of a pressure cuff have been developed and are entering
the consumer market. The majority of the cuffless devices
indirectly measure BP by determining pulse transit time, the
time interval required for a pressure wave in the arterial tree to
travel between 2 sites (ie, a proximal and a distal point). Pulse
transit time is closely related to BP via arterial compliance. Not
only are these devices able to measure BP quickly and
conveniently, but some of them also measure other modalities
such as pulse rate, oxygenation, respiratory rate, and skin
temperature. Furthermore, with respect to BP measurement,
correct cuff size and cuff position are no longer important issues
to take into account for obtaining reliable results. Altogether,
these new cuffless devices could be an excellent alternative to
BP measuring devices based on cuff occlusion, especially for
the purpose of self-measurement.
The Checkme Health Monitor (Viatom Technology, Shenzen,
People’s Republic of China) is a newly released Conformité
Européenne-approved cuffless BP monitoring device. Checkme
is a IIa category medical device compliant with directive
93/42/European Economic Community. As it is aimed at the
consumer market, it has been defined as a screening device for
primary medical checking and not for diagnostic use. However,
for its use in a clinical setting, especially during monitoring of
hypertension treatment, the device’s accuracy in persons with
BPs outside the normal range has to be determined as well.
To ensure the accuracy of new BP monitoring devices, several
protocols have been established, such as the European Society
of Hypertension International Protocol (ESH-IP) revision 2010
[5] and protocols of the Association for the Advancement of
Medical Instrumentation [6,7]. However, a single unified
protocol for all types of BP monitoring devices is still under
development. For example, the ESH-IP and Association for the
Advancement of Medical Instrumentation protocols stipulate
the use of a mercury sphygmomanometer as the reference
device, whereas the International Organization for
Standardization protocol allows use of any type of reference
manometer, as long as it meets the accuracy requirement.
Furthermore, the protocols that have been developed for
validating noninvasive BP devices are designed primarily for
monitors that are intrinsically able to give absolute BP readings
in a single measurement.
Other category devices, such as Checkme, require
patient-specific calibration by a secondary measurement method
or device before they can give absolute BP readings. A protocol
for validating such a monitor must include provisions to assess
the monitor’s accuracy in tracking intrapatient BP changes,
relative to the calibrated level, after a patient-specific calibration
or between calibrations [8].
Another issue in daily practice is that oscillometric devices for
the noninvasive estimation of BP have progressively become
the clinical standard because of the need to train staff in
determining BP by auscultation, cost, and the banning of
mercury in many states and countries [2]. Therefore, it is
conceivable that new devices are being evaluated in comparison
with the easy-to-use automated oscillometric BP devices used
in daily practice.
Finally, with classic BP devices, a correct BP can only be
determined with the detection point (eg, the arm) at heart level.
Because of the assumed method of BP measuring with cuffless
devices, it is still unclear whether the device’s position relative
to the heart may influence the results of the measurement.
The aim of this study was to evaluate the performance of the
first release of the Checkme cuffless BP monitor in a real-life
patient setting. To this purpose, we compared Checkme BP
measurements with measurements from a validated oscillometric
reference BP monitor (RM) according to ESH-IP requirements.
Our second aim was to investigate whether the posture of the
volunteer and the position of the device relative to the heart
level would affect outcomes.
Methods
Checkme
Checkme is a cuffless BP monitoring device, which only
determines SBP. It can be used both in clinical settings and for
self-measurement (Figure 1).
This biometrical device can also measure skin temperature,
heart rate, oxygen saturation, and 1-lead electrocardiogram, and
it can be used as a sleep monitor. Before being able to measure
SBP with Checkme, a personal profile containing sex, age,
weight, and height has to be created, and the device has to be
calibrated with an RM. Calibration is performed by
simultaneously measuring SBP with Checkme and with RM
and entering the SBP of the RM into Checkme after each
measurement. After both calibration measurements, the
Checkme is ready to use. SBP, heart rate, and oxygen saturation
can then be measured by putting the right index finger beneath
the lid on top, the right thumb on the metal plate on front, and
the right middle finger on the metal plate on the back.
Simultaneously, the metal plate on the left side of the device
has to be pressed against the palm of the left hand (Figure
2,Figure 3).
J Med Internet Res 2016 | vol. 18 | iss. 5 | e85 | p.2http://www.jmir.org/2016/5/e85/
(page number not for citation purposes)
Schoot et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Checkme has to be held still at heart level during a measurement.
Performing one measurement takes about 20 seconds. To
evaluate the result, data can be transferred via Bluetooth to a
mobile phone or tablet (supported operating systems are iOS
or Android) with the Checkme app (Figure 4). Details by which
the Checkme measures BP have not been described in the public
domain.
Figure 1. Checkme Health Monitor (Viatom Technology) device.
Figure 2. Checkme position during measurement (front).
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Figure 3. Checkme position during measurement (back).
Reference Device
We used the validated Vital Signs Monitor 300 series (Welch
Allyn, Skaneateles Falls, NY, USA) as RM. This automatic
device measures SBP and DBP in the upper arm by oscillometry.
The normal adult cuff size is suitable for people with an arm
circumference of 25.3–34.4 cm. We used the small adult cuff
when arm circumference was lower (range 20.0–27.0 cm) and
the large adult cuff when arm circumference was higher (range
40.7–55.0 cm).
Familiarization
Before the validation procedure, we took a multiple series of
test measurements using the Checkme and RM to familiarize
ourselves with the devices. To test the study procedure and
familiarize ourselves with it, we measured 2 volunteers
accordingly. We encountered no problems. Experienced
technicians of the Radboud University Medical Center
maintained and calibrated the RM according to the
manufacturer’s protocol.
Recruitment
We recruited study volunteers from patients who visited the
hypertension outpatient services of the Radboud University
Medical Center Department of Internal Medicine. To cover
inclusion in all BP categories in this study, we also recruited
patients with hypertension admitted to the hospital (highest BP
range) and healthy employees (lowest BP range). We stopped
recruitment after obtaining valid measurements of 37 volunteers
with baseline BP measurements in the required ranges.
Exclusion criteria were cardiac arrhythmias, upper-arm
circumference outside the cuff range, and age <25 years.
Information on age, sex, and use of antihypertension medication
was collected and height, body weight, and arm circumference
were measured. All volunteers gave written informed consent.
The institutional review board gave permission for this study
(Medical Research Ethics Committee CMO no. 2015-1717).
Protocol
This study followed the ESH-IP requirements for test
environment, observer qualification, volunteer recruitment, and
BP measurements for the validation of BP measurement devices
[5]. Because device readings are digital, 1 researcher performed
all measurements. In addition to the ESH-IP requirements, we
took measurements in different positions to establish the
influence of posture on device readings.
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Figure 4. The Checkme app, showing heart rate (HR), electrocardiogram (EGC), and oxygen saturation (SpO2).
Each volunteer was seen individually in a quiet,
temperature-controlled room. Appropriate cuff size (in the case
of RM) was chosen based on upper-arm circumference. For
each individual volunteer, a new profile was created on the
Checkme device, with input of sex, date of birth, height, and
weight. Volunteers were given oral instructions regarding proper
use of the Checkme device before measurements were taken.
Baseline measurements were performed with the volunteer in
the supine position after resting for 10 minutes. BP was
measured 3 times at the right upper arm with the RM. The mean
of the last 2 values was used as the baseline value, on the basis
of which volunteers were divided into 1 of 3 BP categories:
high (SBP >160 mmHg), normal (SBP ≥130 and ≤160 mmHg),
or low (SBP <130 mmHg) BP, according to ESH-IP, with at
least 10 volunteers in each BP category.
Next, we calibrated the Checkme device with the volunteer in
the supine position with hands resting on the lower abdomen.
The last measured baseline SBP with the RM was used as the
input value for calibration. After calibration, we randomized
the order of measurements. In the first series of measurements,
BP was measured in the supine position with Checkme at heart
level (arms resting on lower abdomen), Checkme above heart
level (arms stretched above the head at a 90° angle with the
body), and the RM (right upper arm) according to the
randomization order. After the first series of measurements in
the supine position, volunteers were asked to sit up. After 5
minutes of rest, the volunteer’s BP was again measured in
random order with the Checkme at heart level and RM, both in
the upright position. All of the above measurements were
executed 3 times successively. According to ESH-IP, the interval
between consecutive measurements was between 30 and 60
seconds. Failed measurements were repeated up to a maximum
of 3 times.
Statistical Analysis
All statistic calculations were performed with IBM SPSS version
20 (IBM Corporation). To evaluate the influence of the
volunteer’s position on the device readings, we compared the
means of 3 consecutive measurements with a device in the
supine or sitting position by paired samples t -test. A difference
with P<.05 was considered to be significant.
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We excluded 15 of 52 recruited volunteers: 12 due to repeated
BP calibration failures with Checkme, 2 because they appeared
to have low BP (SBP <130 mmHg) with already sufficient data,
and 1 who declined to continue after inclusion. None of the
volunteers had arrhythmias. In <3% of all measurements, BP
had to be measured again due to failure during the first attempt
of both the RM and the Checkme readings.
Study Population
Of the 37 volunteers who completed the study, 14 were in the
low range (SBP <130 mmHg), 13 were in the medium range
(SBP between 130 and 160 mmHg), and 10 were in the high
range (SBP >160 mmHg). Table 1 shows their baseline
characteristics. There were 18 men and 19 women with a mean
age of 54.1 (SD 14.5) years. The mean baseline SBP was 141.7
(SD 24.7) mmHg. For 31 of the 37 volunteers (84%) we used
the normal cuff size of the RM. Due to an arm circumference
above than normal range, the remaining 6 volunteers (16%)
required the large cuff.
Feasibility
In 22 of 52 volunteers (42%), calibration with Checkme failed
the first time (error message: “unstable measure, calibration
failed”). We repeated the procedure up to a maximum of 5 times.
In 5 of 52 volunteers (10%), calibration succeeded after the
second attempt, in 4 (8%) after the third attempt, and in 1 (2%)
after the fifth attempt. Calibration continued to fail in 12 of 52
volunteers (23%), whereupon they were excluded from further
measurements. In 2 of 37 volunteers who completed the study,
the SBP measurement could not be determined in the upright
position.
Comparing BP Results (Primary Aim)
Table 2 shows the BP results for RM and Checkme. Table 3
shows the proportion of patients with differences between RM
and Checkme of >5, >10, and >mmHg. We constructed
Bland-Altman scatter plots of BP differences between RM and
Checkme against the mean BP of the RM and Checkme in the
supine (Figure 5) and upright positions (Figure 6). BP results
correlated with the position of Checkme relative to the heart
level.
Table 1. Study population characteristics.
All volunteers (n=37)Characteristics
18:19Male:female
54.1 (14.5)Age in years, mean (SD)
36 (97)White, n (%)
1 (3)Black, n (%)
172.2 (7.5)Height in m, mean (SD)
83.3 (18.4)Weight in kg, mean (SD)
22 (60)Use of blood pressure-lowering drugs, n (%)
31 (84)Normal cuff size, n (%)
141.7 (24.7)Baseline systolic blood pressure in mmHg, mean (SD)
Table 2. Systolic blood pressure measurements (mmHg) taken by the reference monitor and Checkme in the supine and upright positions.
Range (min; max)aSDMeanaVolunteers’ position
Supine position
84.7 (106.3; 191.0)21.8136.6Reference monitor
94.5 (94.5; 189.0)25.2138.4Checkme at heart level
101.0 (86.0; 187.0)27.7130.7bCheckme above heart
Upright position
100.7 (102.3; 203.0)22.3139.2Reference monitor
87.7 (102.3; 190.0)25.9136.6cCheckme at heart level
aThe average or range of 3 consecutive blood pressure measurements.
bP<.001 compared with Checkme at heart level.
cP=.01 compared with Checkme at heart level in the supine position.
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Table 3. Differences in systolic blood pressure readings between the reference monitor and Checkme in various postures and the proportion of volunteers
with differences >5, >10, and >15 mmHg between the reference monitor and Checkme.
Upright at heart level (n=35)Supine at heart level (n=37)Reading differences
Difference between the devices (mm Hg)
2.6 (12.1)a–1.8 (8.5)Mean (SD)
–35.5; 20.3–19.3; 18.2Min; max of range
Degree of difference
23 (66)17 (46)>5 mmHg, n (%)
15 (43)9 (24)>10 mmHg, n (%)
6 (17)5 (14)>15 mmHg, n (%)
aP=.02 compared with measurements in the supine position.
Figure 5. Bland-Altman plot of the difference in systolic blood pressure readings between the reference monitor (RM) and the Checkme Health Monitor
(at heart level) in the supine position.
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Figure 6. Bland-Altman plot of the difference in systolic blood pressure readings between the reference monitor (RM) and the Checkme Health Monitor
(at heart level) in the upright position.
Influence of Posture on the Device Readings
(Secondary Aim)
Table 2 summarizes the results of the SBP measurements
obtained with RM and Checkme in the various positions. In the
supine position, SBP measured with Checkme above heart level
was significantly lower than SBP measured supine at heart level.
SBP obtained with Checkme in the upright position was
significantly lower than in the supine position, in which the
device is just above heart level. Table 3 summarizes differences
in SBP readings between RM and Checkme in both the supine
and upright positions. The SBP measurement with Checkme in
the upright position was significantly lower than the SBP
measurement with Checkme in the supine position.
Discussion
The results of this comparative study show that the first version
of the Checkme device yields BP results that are to a large
extend comparable with BPs obtained by a validated
oscillometric BP monitor. We observed this for a predefined
wide range of BP levels under well-controlled circumstances.
Furthermore, BP results correlated with the position of Checkme
relative to the heart level. Compared with a reference BP,
Checkme recorded a higher BP below heart level and a lower
BP above heart level.
Due to the lack of a uniform international protocol that includes
provisions to assess intrapatient BP changes relative to the
calibrated level, it was not possible to conduct a formal device
validation study. As the Checkme requires patient-specific
calibration by a secondary measurement device before it can
measure absolute BP, we consider such a protocol to be
necessary.
The strength of this study is that it met all ESH-IP requirements
for test environment, observer qualification, volunteer
recruitment, and BP measurements. Measurements were
conducted in a quiet, temperature-controlled room and the
manufacturer’s guidelines on use of the test device were
followed. Furthermore, we used a validated RM device and
randomized the order of measurements with Checkme and RM
to eliminate the influence of changes in BP over time on the
study results.
Checkme is one of the first cuffless devices to be launched,
indicating that cuffless BP measurement is in its infancy.
Notably, Checkme has outgrown its developmental phase. As
the technique of cuffless devices is continuously being
improved, future generations of Checkme may be even more
suitable for measuring BP in the clinic.
One disadvantage of Checkme is the inability to measure DBP,
because DBP can be used to calculate pulse pressure and adds
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to the overall cardiovascular risk profile. Based on the
underlying method of measuring, a subsequent version of
Checkme may expected to have this ability. Another issue with
the Checkme version used in this study was the inability to
calibrate the device in a substantial number of volunteers.
Repeated attempts to calibrate Checkme after warming
volunteers’ hands and further instructing them to hold still or
change their position were not effective in some of them and
thus further BP measurements were not possible. According to
the manufacturer, a new software release has resolved this
problem.
Ideally, Checkme is calibrated by taking simultaneous BP
measurement with the RM. In this study, we calibrated Checkme
after baseline measurements with the RM. However, as the time
interval between taking the 2 measurements was a maximum 2
minutes (depending on the number of attempts during
calibration), we can assumed that BP had not significantly
altered. Calibration parameter stability over longer periods of
time has yet to be established in further research. After the
completion of this study, Viatom updated the Checkme software
to reduce calibration failures and has provided additional
instructions for positioning Checkme against a lower limb during
the calibration measurements. Therefore, the process of
calibration can be expected to be more successful in future
studies.
Checkme’s BP measuring algorithm has not been made public,
probably for commercial reasons. Most cuffless devices measure
BP indirectly by determining pulse transit time, the time interval
required for a pressure wave in the arterial tree to travel between
2 sites (ie, a proximal and a distal point). Pulse transit time is
closely related to BP via arterial compliance. For example, if
arterial BP increases, arterial wall tension will increase.
Subsequently, arterial compliance and pulse transit time will
decrease [9]. Most cuffless devices calculate pulse transit time
by using the electrocardiogram as the proximal timing reference
and the arterial waveform in an extremity as the distal reference
[10]. Recent research has shown a significant relationship
between BP measured with pulse transit time and BP measured
with conventional devices based on cuff occlusion [11-13].
Differences in BP depending on posture and position of the
device suggest that cuffless BP measurement by Checkme, and
probably in general, is influenced by the position of the device
relative to heart level. This may suggest an inherent error in
Checkme’s algorithm when BP is measured in a position other
than that indicated by the manufacturer. Therefore, it is
important that future users of Checkme conduct all
measurements in the position stipulated in the user manual.
Furthermore, we observed 1 outlier (with SBP difference
between RM and Checkme >40 mmHg), which we could
explain.
If Checkme will be able to fulfill formal international validation
protocol requirements, which include provisions to assess the
monitor’s accuracy in tracking intrapatient BP changes relative
to the calibrated level, after a patient-specific calibration or
between calibrations, we expect increased use of this device.
Especially promising is such devices’ ability to measure BP
faster and more conveniently than conventional BP monitoring
devices based on cuff occlusion. This implies not only that BP
can be measured more efficiently in the clinic, but also that
patients can easily self-monitor their BP at home. Because
self-measurement of BP has been shown to have a positive effect
on reducing BP [3], this easy-to-use BP device will probably
find a place in the management of hypertension. The low costs
of cuffless devices relative to cuff occlusion devices will also
contribute to their implementation in and outside the clinic.
We believe the market of wearable BP sensors will develop in
the areas of self-measurement and remote monitoring. In this
context, device validation may be accelerated if development
of techniques, calculation, and feedback on the basis of clinical
data would take place in an open source environment.
Conclusion
Checkme SBP correlated well with reference SBP, in particular
in the supine position. Although we did not perform a formal
validation study at this preliminary stage, these preliminary
results are most promising and warrant further research on
cuffless BP measurement in the hospital, the clinic, and at home.
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